Infectious Diseases, Bacteriology and Antibiotics

Welcome message

About Conference

The 14th International Conference on Infectious Diseases, Bacteriology and Antibiotics, scheduled for May 26–27, 2027, in Paris, France, is a premier international platform dedicated to advancing research, innovation, and clinical practice in infectious diseases, bacteriology, microbiology, antimicrobial resistance, and antibiotic development. The conference brings together infectious disease specialists, microbiologists, bacteriologists, researchers, clinicians, academicians, healthcare professionals, public health experts, and students from around the world to discuss the latest scientific discoveries, emerging infectious threats, diagnostic technologies, and evidence-based approaches to disease prevention, treatment, and control. Through keynote lectures, scientific sessions, workshops, and panel discussions, participants will gain valuable insights into contemporary challenges and breakthroughs in infectious disease research and global health.

THEME: Transforming Global Health Through Infectious Disease Research and Innovation.

This conference aims to foster interdisciplinary collaboration, encourage knowledge exchange, and promote the development of innovative diagnostics, effective antimicrobial therapies, and sustainable infection prevention strategies. Attendees will have the opportunity to present their research, engage with internationally recognized experts, and build meaningful global collaborations while exploring emerging trends in infectious diseases, bacteriology, microbiology, immunology, and antibiotic research. Set in the vibrant city of Paris, the conference promises two days of scientific excellence, professional development, and international collaboration dedicated to advancing global health.

Why Attend the Conference?

• Explore the latest advancements and research in infectious diseases, bacteriology, and antibiotics.
• Learn from renowned infectious disease specialists, microbiologists, researchers, and healthcare professionals.
• Gain insights into emerging pathogens, antimicrobial resistance, and innovative treatment strategies.
• Network with global experts, academicians, and public health professionals.
• Present your research and exchange ideas with an international audience.
• Participate in engaging scientific sessions, workshops, and panel discussions.
• Expand professional collaborations and career opportunities in infectious diseases and microbiology.
• Experience scientific excellence and global networking in Paris.

Join us for an inspiring international gathering dedicated to advancing infectious disease research, clinical practice, and global public health. The conference offers an excellent opportunity to connect, collaborate, and contribute to the future of infectious diseases, bacteriology, and antibiotic research.

Participation / Presentation Options

The 14th International Conference on Infectious Diseases, Bacteriology and Antibiotics welcomes participants from academia, research institutions, healthcare organizations, pharmaceutical companies, public health agencies, and industry sectors to engage in scientific exchange and professional collaboration. The conference offers diverse participation and presentation opportunities designed to promote knowledge sharing, innovation, and global networking.

Participants can choose from the following options:

Oral Presentation: Present your research findings, clinical studies, or innovative discoveries during the scientific sessions.

Poster Presentation: Showcase your research and interact with delegates and experts through poster presentations.

Virtual Presentation: Participate remotely and present your research online from anywhere in the world.

Workshop Presentation: Conduct interactive workshops focused on infectious disease management, laboratory diagnostics, antimicrobial resistance, or infection prevention and control.

Listener/Delegate Participation: Attend keynote lectures, scientific sessions, and networking events without presenting research.

Exhibitor Opportunities: Organizations, publishers, diagnostic laboratories, healthcare institutions, and pharmaceutical companies can exhibit their products, technologies, and services to an international audience.

Sponsorship Opportunities: Sponsors can enhance their global visibility, connect with leading researchers and healthcare professionals, and promote their brand through various sponsorship packages and conference collaborations.

The conference provides an excellent platform for researchers, clinicians, microbiologists, infectious disease specialists, public health professionals, students, organizations, and industry experts to exchange ideas, build collaborations, and contribute to advancements in infectious diseases, bacteriology, and antibiotic research.

Abstract Review Process

All submitted abstracts for the 14th International Conference on Infectious Diseases, Bacteriology and Antibiotics will undergo a rigorous peer-review process conducted by the conference scientific committee and subject experts. The review process is designed to ensure high scientific quality, relevance, originality, and academic integrity of all accepted presentations.

Each abstract will be evaluated based on:

• Relevance to the conference theme and scientific tracks
• Originality and scientific contribution
• Clarity of objectives, methodology, and results
• Clinical, academic, and public health significance
• Quality of content and overall presentation

Authors will be notified of the review outcome within the specified review timeline. Accepted abstracts will be eligible for oral, poster, or virtual presentation opportunities during the conference. The organizing committee is committed to maintaining a fair, transparent, and high-quality review process that promotes innovative research and meaningful scientific exchange in infectious diseases, bacteriology, and antibiotic research.

VISA Process

We are committed to supporting all international participants in successfully completing their visa application process for attending the 14th International Conference on Infectious Diseases, Bacteriology and Antibiotics in Paris, France. Once your registration is confirmed, the organizing committee will provide the necessary supporting documents, including:

• Official Invitation Letter
• Conference Registration Confirmation
• Proof of Payment Receipt
• Detailed Conference Schedule/Program
• Accommodation Confirmation (if booked through the conference organizers)

These documents are intended to assist participants in fulfilling the visa requirements of the French Embassy or Consulate in their respective countries.

General Visa Requirements

Participants may be required to submit the following documents during the visa application process:

• A valid passport
• Completed visa application form
• Official conference invitation letter
• Proof of accommodation and travel itinerary
• Conference registration confirmation and payment proof
• Additional supporting documents requested by the embassy or consulate

We strongly recommend that participants apply for their visa at least 6–8 weeks in advance to avoid delays or last-minute complications.

In Case of Visa Rejection: Refund & Participation Options

We understand that visa decisions may vary depending on individual circumstances and embassy regulations. To support our participants, the conference offers flexible options in case of visa rejection:

• Participants may switch to Virtual Presentation or Virtual Participation without any additional charges.
• Refund requests must be accompanied by an official visa rejection letter issued by the embassy or consulate.
• Refund requests should be submitted within 10 days of receiving the visa rejection notice.
• Refunds are generally processed within 2–3 weeks after verification of the submitted documents.
• Registration may also be transferred to the next edition of the conference without additional registration fees, if preferred.

Our goal is to ensure that every participant has the opportunity to contribute to the scientific program and remain connected with the global infectious diseases community, regardless of travel limitations.

Market Analysis

The global infectious diseases market continues to expand rapidly, driven by the rising incidence of infectious diseases, increasing antimicrobial resistance, emerging pathogens, and growing investments in diagnostics, vaccines, and antibiotic research.

• The global infectious diseases market is projected to witness significant growth by 2030, supported by advances in diagnostic technologies, vaccine development, and antimicrobial therapies.
• The increasing prevalence of bacterial, viral, fungal, and parasitic infections continues to drive demand for innovative treatment strategies and effective infection control measures.
• Rapid diagnostic technologies, molecular testing, AI-assisted disease surveillance, and digital healthcare solutions are transforming infectious disease diagnosis and management.
• Growing concerns over antimicrobial resistance (AMR) are accelerating research into novel antibiotics, antimicrobial stewardship, and alternative therapeutic approaches.
• Advancements in vaccine development, clinical microbiology, precision medicine, and infection prevention continue to improve patient outcomes and strengthen global health security.
• Governments, healthcare organizations, research institutions, and the pharmaceutical industry are increasing investments in infectious disease research, public health initiatives, and pandemic preparedness.

This conference provides an excellent platform for infectious disease specialists, microbiologists, researchers, healthcare professionals, academicians, and industry experts to explore emerging trends, exchange innovative ideas, build global collaborations, and contribute to advancements in infectious diseases, bacteriology, and antibiotic research.